Nov 16 (Reuters) - Futures tracking the S&P 500 and the Dow rose on Monday after Moderna Inc said its experimental vaccine was 94.5% effective in preventing COVID-19, a week after Pfizer Inc reported positive results from its own late-stage trial.
At 7:00 a.m. ET, Dow e-minis were up 488 points, or 1.66%, and S&P 500 e-minis were up 39.5 points, or 1.1%. Nasdaq 100 e-minis erased early gains to trade down 5.5 points, or 0.05%. (Reporting by Sagarika Jaisinghani in Bengaluru; Editing by Shounak Dasgupta)
Our Standards: The Thomson Reuters Trust Principles.